Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...

Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped around the urethra, as seen in this image taken from Asklepios Atlas of ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Former president Joe Biden was diagnosed May 16 with an aggressive form of prostate cancer, according to a spokesperson. Each year in New York, almost 15,500 men are diagnosed with prostate cancer and ...

Prostate cancer is one of the most common cancers among men in the United States. About one in eight men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up For Black men, and those who love them, it is essential that you ...

Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.